GB0919433D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0919433D0
GB0919433D0 GB0919433A GB0919433A GB0919433D0 GB 0919433 D0 GB0919433 D0 GB 0919433D0 GB 0919433 A GB0919433 A GB 0919433A GB 0919433 A GB0919433 A GB 0919433A GB 0919433 D0 GB0919433 D0 GB 0919433D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0919433A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline LLC filed Critical GlaxoSmithKline LLC
Priority to GB0919433A priority Critical patent/GB0919433D0/en
Publication of GB0919433D0 publication Critical patent/GB0919433D0/en
Priority to UAA201205470A priority patent/UA105675C2/en
Priority to SI201031117T priority patent/SI2722334T1/en
Priority to CN201080050285.XA priority patent/CN102762569B/en
Priority to EP16150637.3A priority patent/EP3037423B1/en
Priority to PL13192666T priority patent/PL2722334T3/en
Priority to SI201030514T priority patent/SI2496580T1/en
Priority to DK10740654.8T priority patent/DK2496580T3/en
Priority to PT131926669T priority patent/PT2722334E/en
Priority to NZ599258A priority patent/NZ599258A/en
Priority to ES10740654.8T priority patent/ES2446647T3/en
Priority to EP10740654.8A priority patent/EP2496580B1/en
Priority to PCT/EP2010/061518 priority patent/WO2011054553A1/en
Priority to DK13192666.9T priority patent/DK2722334T3/en
Priority to MYPI2012001967A priority patent/MY160456A/en
Priority to RS20160102A priority patent/RS54592B1/en
Priority to US13/505,039 priority patent/US9023842B2/en
Priority to JP2012537329A priority patent/JP5524343B2/en
Priority to EP13192666.9A priority patent/EP2722334B1/en
Priority to PE2012000614A priority patent/PE20121181A1/en
Priority to ES13192666.9T priority patent/ES2563057T3/en
Priority to KR1020127014637A priority patent/KR101424989B1/en
Priority to PT107406548T priority patent/PT2496580E/en
Priority to BR112012010706A priority patent/BR112012010706A2/en
Priority to PL10740654T priority patent/PL2496580T3/en
Priority to MX2012005295A priority patent/MX2012005295A/en
Priority to HK13102225.8A priority patent/HK1175458B/en
Priority to ES16150637.3T priority patent/ES2652304T3/en
Priority to HUE13192666A priority patent/HUE026421T2/en
Priority to EA201290183A priority patent/EA020390B1/en
Priority to HRP20140107AT priority patent/HRP20140107T1/en
Priority to CA2779355A priority patent/CA2779355C/en
Priority to MEP-2016-53A priority patent/ME02360B/en
Priority to AU2010314395A priority patent/AU2010314395B2/en
Priority to RS20140088A priority patent/RS53179B/en
Priority to PH1/2012/500894A priority patent/PH12012500894A1/en
Priority to PL10773325T priority patent/PL2496582T3/en
Priority to EA201290184A priority patent/EA023441B1/en
Priority to BR112012010705A priority patent/BR112012010705A2/en
Priority to EP10773325.5A priority patent/EP2496582B1/en
Priority to CN201080060697.1A priority patent/CN102781943B/en
Priority to PCT/EP2010/066697 priority patent/WO2011054845A1/en
Priority to MX2012005296A priority patent/MX341212B/en
Priority to DK10773325.5T priority patent/DK2496582T3/en
Priority to MEP-2016-52A priority patent/ME02356B/en
Priority to ES16152464.0T priority patent/ES2654423T3/en
Priority to HUE10773325A priority patent/HUE026967T2/en
Priority to KR1020127014635A priority patent/KR20120097508A/en
Priority to US13/504,971 priority patent/US9102677B2/en
Priority to RS20160190A priority patent/RS54645B1/en
Priority to ES10773325.5T priority patent/ES2564318T3/en
Priority to AU2010317096A priority patent/AU2010317096B2/en
Priority to HRP20160253TT priority patent/HRP20160253T1/en
Priority to JP2012537381A priority patent/JP5702396B2/en
Priority to EP16152464.0A priority patent/EP3050885B1/en
Priority to SI201031143T priority patent/SI2496582T1/en
Priority to CA2779423A priority patent/CA2779423C/en
Priority to IL219090A priority patent/IL219090A0/en
Priority to DO2012000114A priority patent/DOP2012000114A/en
Priority to IL219253A priority patent/IL219253A/en
Priority to CL2012001178A priority patent/CL2012001178A1/en
Priority to CO12077201A priority patent/CO6540003A2/en
Priority to CR20120283A priority patent/CR20120283A/en
Priority to MA34934A priority patent/MA33803B1/en
Priority to HK14104251.0A priority patent/HK1191012B/en
Priority to CY20141100124T priority patent/CY1114988T1/en
Priority to SM201400024T priority patent/SMT201400024B/en
Priority to IL235983A priority patent/IL235983B/en
Priority to JP2015030132A priority patent/JP2015143232A/en
Priority to US14/684,659 priority patent/US20150210706A1/en
Priority to AU2015203454A priority patent/AU2015203454B2/en
Priority to IL239625A priority patent/IL239625B/en
Priority to US14/753,326 priority patent/US9598420B2/en
Priority to HRP20160119TT priority patent/HRP20160119T1/en
Priority to CY20161100172T priority patent/CY1117479T1/en
Priority to CY20161100231T priority patent/CY1117424T1/en
Priority to SM201600081T priority patent/SMT201600081B/en
Priority to SM201600104T priority patent/SMT201600104B/en
Priority to HK16108220.7A priority patent/HK1220188A1/en
Priority to HK16109359.8A priority patent/HK1221221A1/en
Priority to JP2016185487A priority patent/JP2017039738A/en
Priority to US15/410,874 priority patent/US20170197972A1/en
Priority to US15/426,294 priority patent/US20170145021A1/en
Ceased legal-status Critical Current

Links

GB0919433A 2009-11-05 2009-11-05 Novel compounds Ceased GB0919433D0 (en)

Priority Applications (83)

Application Number Priority Date Filing Date Title
GB0919433A GB0919433D0 (en) 2009-11-05 2009-11-05 Novel compounds
UAA201205470A UA105675C2 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
SI201031117T SI2722334T1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
CN201080050285.XA CN102762569B (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
EP16150637.3A EP3037423B1 (en) 2009-11-05 2010-08-06 Novel benzodiazepine compound
PL13192666T PL2722334T3 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
SI201030514T SI2496580T1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
DK10740654.8T DK2496580T3 (en) 2009-11-05 2010-08-06 Benzodiazepine bromine domain inhibitor
PT131926669T PT2722334E (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
NZ599258A NZ599258A (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
ES10740654.8T ES2446647T3 (en) 2009-11-05 2010-08-06 Benzodiazepine Bromodomain Inhibitor
EP10740654.8A EP2496580B1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
PCT/EP2010/061518 WO2011054553A1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
DK13192666.9T DK2722334T3 (en) 2009-11-05 2010-08-06 benzodiazepine bromdomæneinhibitor
MYPI2012001967A MY160456A (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
RS20160102A RS54592B1 (en) 2009-11-05 2010-08-06 BENZODIAZEPINE BROMODOMEN INHIBITOR
US13/505,039 US9023842B2 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
JP2012537329A JP5524343B2 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
EP13192666.9A EP2722334B1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
PE2012000614A PE20121181A1 (en) 2009-11-05 2010-08-06 BENZODIAZEPINE BROMODOMINIUM INHIBITOR
ES13192666.9T ES2563057T3 (en) 2009-11-05 2010-08-06 Benzodiazepine Bromodomain Inhibitor
KR1020127014637A KR101424989B1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
PT107406548T PT2496580E (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
BR112012010706A BR112012010706A2 (en) 2009-11-05 2010-08-06 compound, pharmaceutical composition, pharmaceutical combination, use of a compound, and methods for treating a disease or condition, and for inhibiting bromodomain
PL10740654T PL2496580T3 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
MX2012005295A MX2012005295A (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor.
HK13102225.8A HK1175458B (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
ES16150637.3T ES2652304T3 (en) 2009-11-05 2010-08-06 Novel benzodiazepine compound
HUE13192666A HUE026421T2 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
EA201290183A EA020390B1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
HRP20140107AT HRP20140107T1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
CA2779355A CA2779355C (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
MEP-2016-53A ME02360B (en) 2009-11-05 2010-08-06 Benzodiazepine Bromine Domain Inhibitor
AU2010314395A AU2010314395B2 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
RS20140088A RS53179B (en) 2009-11-05 2010-08-06 BENZODIAZEPINSKI INHIBITOR BROMODOMENA
PH1/2012/500894A PH12012500894A1 (en) 2009-11-05 2010-08-06 Benzodiazepine bromodomain inhibitor
PL10773325T PL2496582T3 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
EA201290184A EA023441B1 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
BR112012010705A BR112012010705A2 (en) 2009-11-05 2010-11-03 compound, pharmaceutical composition, combined pharmaceutical product, use of a compound, and methods for treating a disease or condition, and for inhibiting bromodomain
EP10773325.5A EP2496582B1 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
CN201080060697.1A CN102781943B (en) 2009-11-05 2010-11-03 Benzodiazepine * bromine domain inhibitor
PCT/EP2010/066697 WO2011054845A1 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
MX2012005296A MX341212B (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor.
DK10773325.5T DK2496582T3 (en) 2009-11-05 2010-11-03 Benzodiazepine-BROMDOMAeNEINHIBITOR.
MEP-2016-52A ME02356B (en) 2009-11-05 2010-11-03 BENZODIAZEPINE-BROMDÄNENENHEMMER
ES16152464.0T ES2654423T3 (en) 2009-11-05 2010-11-03 Benzodiazepine Bromodomain Inhibitor
HUE10773325A HUE026967T2 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
KR1020127014635A KR20120097508A (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
US13/504,971 US9102677B2 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
RS20160190A RS54645B1 (en) 2009-11-05 2010-11-03 BENZODIAZEPINE AS A BROMODOMEN INHIBITOR
ES10773325.5T ES2564318T3 (en) 2009-11-05 2010-11-03 Benzodiazepine Bromodomain Inhibitor
AU2010317096A AU2010317096B2 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
HRP20160253TT HRP20160253T1 (en) 2009-11-05 2010-11-03 BENZODIAZEPINE BROMODOMEN INHIBITOR
JP2012537381A JP5702396B2 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
EP16152464.0A EP3050885B1 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
SI201031143T SI2496582T1 (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
CA2779423A CA2779423C (en) 2009-11-05 2010-11-03 Benzodiazepine bromodomain inhibitor
IL219090A IL219090A0 (en) 2009-11-05 2012-04-05 Benzodiazepine bromodomain inhibitor
DO2012000114A DOP2012000114A (en) 2009-11-05 2012-04-18 BROMODOMINIUM INHIBITOR OF BENZODIAZEPINA
IL219253A IL219253A (en) 2009-11-05 2012-04-18 Benzodiazepine bromodomain inhibitor for use in the treatment of cancer
CL2012001178A CL2012001178A1 (en) 2009-11-05 2012-05-04 2 - [(4s) -6- (4-chloro-phenyl) -1-methyl-8- (methyloxy) -4h- [1,2,4] -triazolo- [4,3-a] [1,4 ] -benzo-diazepin-4-yl] -n-ethyl-acetamide or a salt; composition and pharmaceutical combination; and use in the treatment of chronic autoimmune and / or inflammatory diseases and cancer.
CO12077201A CO6540003A2 (en) 2009-11-05 2012-05-10 BENZODIAZEPINA BROMODOMINIUM INHIBITOR
CR20120283A CR20120283A (en) 2009-11-05 2012-05-28 BENZODIAZEPINA BROMODOMINIUM INHIBITOR
MA34934A MA33803B1 (en) 2009-11-05 2012-06-04 BENZODIAZEPINE BROMODOMAINE INHIBITOR
HK14104251.0A HK1191012B (en) 2009-11-05 2013-02-21 Benzodiazepine bromodomain inhibitor
CY20141100124T CY1114988T1 (en) 2009-11-05 2014-02-18 BROMODOMAIN BENZODIAZEPIN RISK
SM201400024T SMT201400024B (en) 2009-11-05 2014-02-20 Bromodomain inhibitor of benzodiazepines
IL235983A IL235983B (en) 2009-11-05 2014-11-30 2-[(4s)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4h-s-triazolo[4,3-a][1,4]benzodiazepin-4-yl]-n-ethylacetamide, salts thereof and pharmaceutical compositions comprising them
JP2015030132A JP2015143232A (en) 2009-11-05 2015-02-19 Benzodiazepine bromodomain inhibitor
US14/684,659 US20150210706A1 (en) 2009-11-05 2015-04-13 Benzodiazepine Bromodomain Inhibitor
AU2015203454A AU2015203454B2 (en) 2009-11-05 2015-06-23 Benzodiazepine bromodomain inhibitor
IL239625A IL239625B (en) 2009-11-05 2015-06-25 Benzodiazepine bromodomain inhibitor
US14/753,326 US9598420B2 (en) 2009-11-05 2015-06-29 Benzodiazepine bromodomain inhibitor
HRP20160119TT HRP20160119T1 (en) 2009-11-05 2016-02-03 Benzodiazepine bromodomain inhibitor
CY20161100172T CY1117479T1 (en) 2009-11-05 2016-03-01 BROMODOMAIN BENZODIAZEPINIC SUSPENSION
CY20161100231T CY1117424T1 (en) 2009-11-05 2016-03-18 BROMODOMAIN BENZODIAZEPINIC SUSPENSION
SM201600081T SMT201600081B (en) 2009-11-05 2016-03-22 BENZODIAZEPINE BROMODOMYN INHIBITOR
SM201600104T SMT201600104B (en) 2009-11-05 2016-04-13 BENZODIAZEPIN BROMODOMYN INHIBITOR
HK16108220.7A HK1220188A1 (en) 2009-11-05 2016-07-13 Novel benzodiazepine compound
HK16109359.8A HK1221221A1 (en) 2009-11-05 2016-08-05 Benzodiazepine bromodomain inhibitor
JP2016185487A JP2017039738A (en) 2009-11-05 2016-09-23 Benzodiazepine bromodomain inhibitor
US15/410,874 US20170197972A1 (en) 2009-11-05 2017-01-20 Benzodiazepine bromodomain inhibitor
US15/426,294 US20170145021A1 (en) 2009-11-05 2017-02-07 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0919433A GB0919433D0 (en) 2009-11-05 2009-11-05 Novel compounds

Publications (1)

Publication Number Publication Date
GB0919433D0 true GB0919433D0 (en) 2009-12-23

Family

ID=41501976

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0919433A Ceased GB0919433D0 (en) 2009-11-05 2009-11-05 Novel compounds

Country Status (2)

Country Link
GB (1) GB0919433D0 (en)
UA (1) UA105675C2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018526424A (en) 2015-09-11 2018-09-13 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド Acetamidhienotriazolodiazepines and their use
CR20180336A (en) * 2015-11-25 2018-08-06 Dana Farber Cancer Inst Inc BIVALENT BROMODOMINIUM INHIBITORS AND USES OF THE SAME

Also Published As

Publication number Publication date
UA105675C2 (en) 2014-06-10

Similar Documents

Publication Publication Date Title
GB0919423D0 (en) Novel compounds
GB0919434D0 (en) Novel compounds
GB0919426D0 (en) Novel compounds
EP2483254A4 (en) Novel compounds
GB0905955D0 (en) Novel compounds
EP2512242A4 (en) Novel compounds
GB0910674D0 (en) Novel compounds
GB0910691D0 (en) Novel compounds
GB0919433D0 (en) Novel compounds
GB0910689D0 (en) Novel compounds
GB0910009D0 (en) Novel compounds
GB0910688D0 (en) Novel compounds
GB0910667D0 (en) Novel compounds
GB0907112D0 (en) Novel compounds
GB0910686D0 (en) Novel compounds
GB0907116D0 (en) Novel compounds
GB0907117D0 (en) Novel compounds
GB0907113D0 (en) Novel compounds
GB0907131D0 (en) Novel compounds
GB0907136D0 (en) Novel compounds
GB0907137D0 (en) Novel compounds
GB0907204D0 (en) Novel compounds
GB0907820D0 (en) Novel compounds
GB0908799D0 (en) Novel compounds
GB0909303D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)